Finance

Lists
Why is C68 up 4,42%?
Dive Deeper
C68:FRA
Crescent Biopharma Inc
11,80 €
+4,42%
(+0,50) 1D
9-окт., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for C68...
Open
11,80 €
High
11,80 €
Low
11,80 €
Mkt. cap
553,82 млн
Avg. vol.
13,00
Volume
0,00
52-wk high
22,80 €
52-wk low
6,70 €
No. of employees
69
Open
11,80 €
High
11,80 €
Low
11,80 €
Mkt. cap
553,82 млн
Avg. vol.
13,00
Volume
0,00
52-wk high
22,80 €
52-wk low
6,70 €
No. of employees
69
News stories
From web sources and news partners
About Crescent Biopharma Inc
CEO-
Employees69
Founded2024
HeadquartersУолтем, Массачусетс, Америка Кошмо Штаттары
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
10,84 млн
1,04 млн
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20,35 млн
95,03 млн
17,90 млн
19,39 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,54 млн
7,31 млн
7,86 млн
8,74 млн
Operating expense
25,88 млн
102,34 млн
25,77 млн
28,13 млн
Total operating expenses
25,88 млн
102,34 млн
25,77 млн
28,13 млн
Operating income
-25,88 млн
-91,49 млн
-24,73 млн
-28,13 млн
Other non operating income
-
-
-
-
EBT including unusual items
-24,61 млн
-90,40 млн
-23,28 млн
-24,84 млн
EBT excluding unusual items
-24,61 млн
-90,40 млн
-23,28 млн
-26,61 млн
Income tax expense
-
2,00 млн
-
-
Effective tax rate
-
-2,21%
-
-
Other operating expenses
-
-
-
-
Net income
-24,61 млн
-92,40 млн
-23,28 млн
-24,84 млн
Net profit margin
-
-852,06%
-2 240,90%
-
Earnings per share
-1,37
-4,92
-0,70
-0,62
Interest and investment income
1,28 млн
1,10 млн
1,45 млн
1,53 млн
Interest expense
-
-
-
-
Net interest expenses
1,28 млн
1,10 млн
1,45 млн
1,53 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-25,86 млн
-91,44 млн
-24,66 млн
-28,07 млн
Gain or loss from assets sale
-
-
-
-1,77 млн
AI content may include mistakes. Learn more
Google колдонмолору